1 / 22

Key Insights from the 2013 AAN Meeting: Advancements in Neurology and Clinical Practice

This summary captures key insights from the 2013 American Academy of Neurology meeting, focusing on translating clinical data into practical applications. Topics include combination therapy, injectable and oral disease-modifying therapies like Fingolimod, Teriflunomide, Natalizumab, and BG-12 (Dimethyl Fumarate), as well as balancing safety and efficacy in treatment. Special attention is given to considerations around pregnancy. The document outlines future directions in neurology and summarizes critical points discussed during the meeting.

brent-vinson
Télécharger la présentation

Key Insights from the 2013 AAN Meeting: Advancements in Neurology and Clinical Practice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Key Insights From the 2013 American Academy of Neurology Meeting:Translating Clinical Data Into Clinical Practice

  2. Disclosure

  3. Disclaimer

  4. Program Goals

  5. Combination Therapy

  6. Relapse

  7. Injectable Therapy

  8. Balancing Safety and Efficacy

  9. Oral Disease-Modifying Therapies

  10. Fingolimod

  11. Teriflunomide

  12. Natalizumab

  13. Pregnancy

  14. BG-12 (Dimethyl Fumarate)

  15. Future Directions

  16. Summary and Key Points

  17. Abbreviations

  18. Abbreviations (cont)

  19. References

  20. References (cont)

  21. References (cont)

More Related